Eurosiskin Dental Stone Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 4.90 M
as on 28-05-2024
- Revenue 604.94%
(FY 2017)
- Profit 23.03%
(FY 2017)
- Ebitda 70.16%
(FY 2017)
- Net Worth -67.03%
(FY 2017)
- Total Assets -19.39%
(FY 2017)
About Eurosiskin Dental Stone
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.90 M.
Thomas Abraham and Alan Jose serve as directors at the Company.
- CIN/LLPIN
U26992KL2014PTC036125
- Company No.
036125
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2014
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kottayam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Eurosiskin Dental Stone Private Limited offer?
Eurosiskin Dental Stone Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Filling Material.
Who are the key members and board of directors at Eurosiskin Dental Stone?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Thomas Abraham | Managing Director | 10-Feb-2014 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alan Jose | Director | 10-Feb-2014 | Current |
Financial Performance of Eurosiskin Dental Stone.
Eurosiskin Dental Stone Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 604.94% increase. The company also saw a substantial improvement in profitability, with a 23.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 67.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Eurosiskin Dental Stone?
In 2017, Eurosiskin Dental Stone had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Canara Bank Creation Date: 27 Feb 2015 | ₹3.90 M | Open |
Canara Bank Creation Date: 27 Feb 2015 | ₹1.00 M | Open |
How Many Employees Work at Eurosiskin Dental Stone?
Unlock and access historical data on people associated with Eurosiskin Dental Stone, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurosiskin Dental Stone, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurosiskin Dental Stone's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.